All Companies

Companysort icon Description Status Initial Date
<a href="/venture-capital/all-companies/cgi-pharmaceuticals-inc">CGI Pharmaceuticals, Inc.</a> Developing small molecule therapeutics for multiple oncology and immunology-based indications Acquired 2001 View Profile
ChemGenics Pharmaceuticals Genetically directed drug discovery focused on fungal bacterial diseases Acquired 1992 View Profile
<a href="/venture-capital/all-companies/color-kinetics">Color Kinetics</a> Pioneer in the design, marketing and licensing of intelligent solid-state lighting systems Acquired 1997 View Profile
<a href="/venture-capital/all-companies/concert-pharmaceuticals-inc">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. Public 2006 View Profile
<a href="/venture-capital/all-companies/cytyc">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health Public 1989 View Profile
<a href="/venture-capital/all-companies/ecosense-lighting%C2%AE">EcoSense Lighting®</a> Providing best-in-class LED lighting solutions for use in commercial and architectural applications. Private 2013 View Profile
<a href="/venture-capital/all-companies/editas-medicine">Editas Medicine</a> Leading genome editing company translating its proprietary technology into novel solutions to treat a broad range of genetically-driven diseases. Private 2013 View Profile
<a href="/venture-capital/all-companies/eleven-biotherapeutics-inc">Eleven Biotherapeutics, Inc.</a> Discovering and developing protein therapeutics to treat diseases of the eye. Public 2008 View Profile
<a href="/venture-capital/all-companies/ensemble-therapeutics-corporation">Ensemble Therapeutics Corporation</a> Deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. Private 2004 View Profile
<a href="/venture-capital/all-companies/epitome-biosystems">Epitome Biosystems</a> Developing novel protein measurement systems based on Protien Epitope Tag technology Acquired 2003 View Profile
<a href="/venture-capital/all-companies/exact-sciences">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers Public 1995 View Profile
<a href="/venture-capital/all-companies/genomics-collaborative">Genomics Collaborative</a> Large repository of human DNA, serum and tissue samples linked to detailed clinical information Acquired 2000 View Profile
<a href="/venture-capital/all-companies/hypnion-inc">Hypnion, Inc.</a> Platform technology enabling novel therapies for treatment of sleep disorders Acquired 2007 View Profile
<a href="/venture-capital/all-companies/idexx-laboratories">IDEXX Laboratories</a> Products that enhance the ability of veterinarians to economically provide advanced medical care Public 1991 View Profile
<a href="/venture-capital/all-companies/insmed-incorporated">INSMED, Incorporated</a> Pharmaceuticals for treatment of metabolic diseases and endocrine disorders Public 1996 View Profile
<a href="/venture-capital/all-companies/intellivid">IntelliVid</a> Machine intelligence for video security Acquired 2002 View Profile
<a href="/venture-capital/all-companies/interactive-supercomputing-corporation">Interactive Supercomputing Corporation</a> Software to enable applications transparent use of cluster supercomputers Acquired 2005 View Profile
<a href="/venture-capital/all-companies/intio">INTIO</a> Developing a software platform to support the emerging interventional oncology market. Private 2005 View Profile
<a href="/venture-capital/all-companies/joule-unlimited-inc">Joule Unlimited, Inc.</a> Pioneering a CO2-to-fuel production platform, effectively reversing combustion through the use of solar energy. Private 2007 View Profile
<a href="/venture-capital/all-companies/ls9">LS9</a> Leading renewable chemical technology developer. Acquired 2005 View Profile